Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-05-06

FDA Approved: CERIANNA — Supplemental Application (GE Healthcare Inc.)

View source ↗

Summary

FDA approved a supplemental application for CERIANNA (fluoroestradiol F-18) from GE Healthcare Inc. The action updates the product's approval status as part of …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CERIANNA (Fluoroestradiol F-18)

Snippet

SUPPL AP for CERIANNA (FLUOROESTRADIOL F 18)